Science ❯ Biotechnology ❯ Drug Research

Clinical Trials

Phase 1 Trials Weight Loss Medications Neuromuscular Diseases Phase 3 Trials Market Approval Processes Late-Stage Testing Pharmacokinetics Therapeutics Regulatory Approval Market Predictions FDA Approval Oncology Programs

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

Targeting mutant KRAS through cyclophilin A, the pill has been made available under an FDA expanded access pathway pending formal review.

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

European Commission Authorizes Gobivaz, First Simponi Biosimilar, Across the EEA